Annual EBITDA
-$9.57 M
-$715.00 K-8.08%
December 31, 2023
Summary
- As of February 26, 2025, PRFX annual EBITDA is -$9.57 million, with the most recent change of -$715.00 thousand (-8.08%) on December 31, 2023.
- During the last 3 years, PRFX annual EBITDA has fallen by -$6.72 million (-236.23%).
- PRFX annual EBITDA is now -1798.61% below its all-time high of -$504.00 thousand, reached on December 31, 2018.
Performance
PRFX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$7.34 M
-$1.78 M-32.01%
June 30, 2024
Summary
- As of February 26, 2025, PRFX quarterly EBITDA is -$7.34 million, with the most recent change of -$1.78 million (-32.01%) on June 30, 2024.
- Over the past year, PRFX quarterly EBITDA has stayed the same.
- PRFX quarterly EBITDA is now -1699.26% below its all-time high of -$408.00 thousand, reached on June 30, 2020.
Performance
PRFX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$17.81 M
-$5.09 M-40.05%
June 30, 2024
Summary
- As of February 26, 2025, PRFX TTM EBITDA is -$17.81 million, with the most recent change of -$5.09 million (-40.05%) on June 30, 2024.
- Over the past year, PRFX TTM EBITDA has stayed the same.
- PRFX TTM EBITDA is now -1806.75% below its all-time high of -$934.00 thousand, reached on March 31, 2020.
Performance
PRFX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
PRFX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -8.1% | 0.0% | 0.0% |
| 3 y3 years | -236.2% | 0.0% | 0.0% |
| 5 y5 years | -1798.6% | 0.0% | 0.0% |
PRFX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -32.9% | at low | -444.2% | at low | -160.6% | at low |
| 5 y | 5-year | -1198.4% | at low | -1699.3% | at low | -1806.8% | at low |
| alltime | all time | -1798.6% | at low | -1699.3% | at low | -1806.8% | at low |
PainReform EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2024 | - | -$7.34 M(+32.0%) | -$17.81 M(+40.1%) |
| Mar 2024 | - | -$5.56 M(+56.3%) | -$12.72 M(+32.9%) |
| Dec 2023 | -$9.57 M(+8.1%) | -$3.56 M(+163.8%) | -$9.57 M(+3.3%) |
| Sep 2023 | - | -$1.35 M(-40.0%) | -$9.26 M(-7.4%) |
| Jun 2023 | - | -$2.25 M(-6.9%) | -$10.00 M(+4.2%) |
| Mar 2023 | - | -$2.41 M(-25.7%) | -$9.60 M(+8.4%) |
| Dec 2022 | -$8.85 M(+23.0%) | -$3.25 M(+55.6%) | -$8.85 M(+20.6%) |
| Sep 2022 | - | -$2.09 M(+13.2%) | -$7.34 M(+4.6%) |
| Jun 2022 | - | -$1.84 M(+10.5%) | -$7.02 M(+2.7%) |
| Mar 2022 | - | -$1.67 M(-3.9%) | -$6.83 M(-5.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$7.20 M(+153.0%) | -$1.74 M(-1.6%) | -$7.20 M(+15.3%) |
| Sep 2021 | - | -$1.77 M(+6.4%) | -$6.24 M(+20.1%) |
| Jun 2021 | - | -$1.66 M(-18.6%) | -$5.20 M(+31.7%) |
| Mar 2021 | - | -$2.04 M(+160.9%) | -$3.95 M(+38.8%) |
| Dec 2020 | -$2.85 M(+286.2%) | -$781.00 K(+8.0%) | -$2.85 M(+37.8%) |
| Sep 2020 | - | -$723.00 K(+77.2%) | -$2.06 M(+53.9%) |
| Jun 2020 | - | -$408.00 K(-56.3%) | -$1.34 M(+43.7%) |
| Mar 2020 | - | -$934.00 K | -$934.00 K |
| Dec 2019 | -$737.00 K(+46.2%) | - | - |
| Dec 2018 | -$504.00 K | - | - |
FAQ
- What is PainReform annual EBITDA?
- What is the all time high annual EBITDA for PainReform?
- What is PainReform annual EBITDA year-on-year change?
- What is PainReform quarterly EBITDA?
- What is the all time high quarterly EBITDA for PainReform?
- What is PainReform quarterly EBITDA year-on-year change?
- What is PainReform TTM EBITDA?
- What is the all time high TTM EBITDA for PainReform?
- What is PainReform TTM EBITDA year-on-year change?
What is PainReform annual EBITDA?
The current annual EBITDA of PRFX is -$9.57 M
What is the all time high annual EBITDA for PainReform?
PainReform all-time high annual EBITDA is -$504.00 K
What is PainReform annual EBITDA year-on-year change?
Over the past year, PRFX annual EBITDA has changed by -$715.00 K (-8.08%)
What is PainReform quarterly EBITDA?
The current quarterly EBITDA of PRFX is -$7.34 M
What is the all time high quarterly EBITDA for PainReform?
PainReform all-time high quarterly EBITDA is -$408.00 K
What is PainReform quarterly EBITDA year-on-year change?
Over the past year, PRFX quarterly EBITDA has changed by $0.00 (0.00%)
What is PainReform TTM EBITDA?
The current TTM EBITDA of PRFX is -$17.81 M
What is the all time high TTM EBITDA for PainReform?
PainReform all-time high TTM EBITDA is -$934.00 K
What is PainReform TTM EBITDA year-on-year change?
Over the past year, PRFX TTM EBITDA has changed by $0.00 (0.00%)